Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing
AssigneeDarwin Molecular Corporation
InventorsLawrence A. Loeb, John M. Essigmann
Life of this patent
Estimating the term…
Abstract
Methods and compositions related to HIV are disclosed. Using the methods of the present invention, nucleoside analogs may be screened for the ability to be incorporated by reverse transcriptase of human immunodeficiency virus ("HIV RT") and cause incorrect base pairing. Progressive mutation of the virus by such nucleoside analogs renders it non-viable.
Claims7
A method of screening for a nucleoside analog that is incorporated and extended at high efficiency by reverse transcriptase of human immunodeficiency virus (HIV RT) and causes incorrect base pairing, comprising:
- (a) determining incorporation and extension by HIV RT of a nucleoside analog;
- and
- (b) testing the mutagenic potential of said analog, thereby determining whether said analog causes incorrect base pairing.
A method of screening for a nucleoside analog that is incorporated and extended at high efficiency by reverse transcriptase of human immunodeficiency virus (HIV RT) and causes incorrect base pairing, comprising:
- (a) testing a mixture of nucleoside analogs for incorporation by HIV RT;
- (b) purifying said mixture to yield a plurality of purified analogs;
- (c) determining incorporation and extension by HIV RT of a purified analog;
- and
- (d) testing the mutagenic potential of said purified analog, thereby determining whether said analog causes incorrect base pairing.
A method of screening for a nucleoside analog that is incorporated and extended at high efficiency by reverse transcriptase of human immunodeficiency virus (HIV RT) and causes incorrect base pairing, said analog incorporated preferentially by HIV RT relative to incorporation by a mammalian DNA polymerase, comprising:
- (a) determining incorporation and extension by HIV RT of a nucleoside analog;
- (b) testing the mutagenic potential of said analog, thereby determining whether said analog causes incorrect base pairing.
- (c) determining incorporation by a mammalian DNA polymerase of said analog;
- and
- (d) comparing the incorporation in steps (a) and (c), therefrom determining whether said analog is incorporated preferentially by HIV RT.
A method of screening for a nucleoside analog that is incorporated and extended at high efficiency by reverse transcriptase of human immunodeficiency virus (HIV RT) and causes incorrect base pairing, said analog incorporated preferentially by HIV RT relative to incorporation by a mammalian DNA polymerase, comprising:
- (a) testing the mutagenic potential of a nucleoside analog, thereby determining whether said analog causes incorrect base pairing;
- (b) determining extension by HIV RT of said analog;
- and
- (c) comparing incorporation by HIV RT of said analog with incorporation by a mammalian DNA polymerase, therefrom determining whether said analog is incorporated preferentially by HIV RT.
A method of screening for a nucleoside analog that is incorporated and extended at High efficiency by reverse transcriptase of human immunodeficiency virus (HIV RT) and causes incorrect base pairing, said analog incorporated preferentially by HIV RT relative to incorporation by a mammalian DNA polymerase, comprising:
- (a) testing a mixture of nucleoside analogs for incorporation by HIV RT;
- (b) purifying said mixture to yield a plurality of purified analogs;
- (c) determining incorporation and extension by HIV RT of a purified analog;
- (d) testing the mutagenic potential of said purified analog, thereby determining whether said analog causes incorrect base pairing;
- (e) determining incorporation by mammalian DNA polymerase of said purified analog;
- and
- (f) comparing the incorporation in steps (c) and (e), therefrom determining whether said purified analog is incorporated preferentially by HIV RT.
A method of screening for a nucleoside analog that is incorporated and extended at high efficiency by reverse transcriptase of human immunodeficiency virus (HIV RT) and causes incorrect base pairing, said analog incorporated preferentially by HIV RT relative to incorporation by a mammalian DNA polymerase, comprising:
- (a) testing a mixture of nucleoside analogs for incorporation by HIV RT;
- (b) purifying said mixture to yield a plurality of purified analogs;
- (c) testing the mutagenic potential of a purified analog, thereby determining whether said analog causes incorrect base pairing;
- (d) determining extension by HIV RT of said analog;
- and
- (e) comparing incorporation by HIV RT of said purified analog with incorporation by a mammalian DNA polymerase, therefrom determining whether said purified analog is incorporated preferentially by HIV RT.
Dependencies are inferred from the claim text.